Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5828243 | 0.94 | GPR84 (0.50) | CA2MAPK1GPR84FFAR1SLC1A2 | |
| SCHEMBL2371368 | 0.92 | GPR84 (0.53) | CA2GPR84FFAR1MAPTLCK | |
| SCHEMBL2372025 | 0.92 | GPR84 (0.53) | CA2GPR84FFAR1MAPTLCK | |
| SCHEMBL6294388 | 0.92 | GPR84 (0.53) | CA2GPR84FFAR1MAPTLCK | |
| SCHEMBL2371871 | 0.92 | GPR84 (0.53) | CA2GPR84FFAR1MAPTLCK | |
| SCHEMBL2380100 | 0.92 | GPR84 (0.53) | CA2GPR84FFAR1MAPTLCK | |
| SCHEMBL2370725 | 0.92 | GPR84 (0.53) | CA2GPR84FFAR1MAPTLCK | |
| SCHEMBL2370650 | 0.92 | GPR84 (0.53) | CA2GPR84FFAR1MAPTLCK | |
| SCHEMBL2371272 | 0.92 | GPR84 (0.53) | CA2GPR84FFAR1MAPTLCK | |
| SCHEMBL2371133 | 0.92 | GPR84 (0.53) | CA2GPR84FFAR1MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119191985-A | Method for preparing 6-nitrohexanoic acid from aminocaproic acid and application thereof | 上海荣迪生物技术有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-20090246169-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | NYCOMED GMBH (DE) | 2009-10-01 | — | — | US | disclosed |
| EP-1994033-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | 4SC AG (DE) | 2008-11-26 | — | — | EP | disclosed |
| CN-100375741-C | Process for producing lactams | ASAHI CHEMICAL IND (JP) | 2008-03-19 | — | — | CN | disclosed |
| WO-2007096395-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | 4SC AG (DE) | 2007-08-30 | — | — | WO | disclosed |
| CN-1553896-A | Process for producing lactams | ɻ�ѧ��ʽ���� | 2004-12-08 | — | — | CN | disclosed |
| US-4138586-A | NITROALKANECARBOXYLIC ESTER WITH ALKALI HYDROXIDE, OZONIZING | HOFFMANN-LA ROCHE INC. (US) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090246169-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | KIF5A, KIF5C, KIF5B | CA2 3474/4885MAPK1 1011/4885GPR84 2303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.